Revolution Healthcare Acquisition - Warrants (17/03/2026) OverviewRevolution Healthcare Acquisition - Warrants (17/03/2026)'s EBIT is $-800B, below the sector sector average of $-9.6M.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022
The latest EBIT for REVHW is $-800B as of September 2022. That is below the sector sector average of $-9.6M. Investors often review this figure alongside Revolution Healthcare Acquisition - Warrants (17/03/2026)'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, REVHW currently prints $-800B for EBIT, while the sector average sits near $-9.6M. That is roughly 8282776.2% below the sector mean. Large gaps often invite a closer look at Revolution Healthcare Acquisition - Warrants (17/03/2026)'s growth, margins, and balance sheet.
A EBIT figure of $-800B for REVHW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-9.6M. Explore the charts below for those layers of context.
After noting REVHW's EBIT ($-800B), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
